Sorenson John Bradley
Known title: SVP, Global Supply ChainCIK: 0001629277
Associated companies
Transaction History
| BSX | ▼ Sell | Open Market | 4,572 | $478K | 5/5/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,204 | $0 | 5/2/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,918 | $201K | 5/2/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 3,303 | $347K | 2/19/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 2,657 | $277K | 2/18/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,500 | $0 | 2/17/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 684 | $73K | 2/17/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,273 | $0 | 2/16/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 581 | $62K | 2/16/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,115 | $0 | 2/14/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 965 | $102K | 2/14/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 1,201 | $128K | 2/14/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,731 | $0 | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 530 | $56K | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 6,389 | $671K | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Gift | 2,156 | $0 | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 3,793 | $402K | 2/11/2025 | View on chart |
| BSX | ▲ Buy | Grant | 10,182 | $0 | 2/11/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 6,528 | $685K | 2/7/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 2,342 | $210K | 1/3/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 4,119 | $371K | 1/2/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,469 | $0 | 1/1/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 2,127 | $190K | 1/1/2025 | View on chart |
| BSX | ▼ Sell | Gift | 2,610 | $0 | 11/12/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 17,362 | $426K | 11/8/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 30,580 | $2.7M | 11/8/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,203 | $0 | 5/2/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,917 | $138K | 5/2/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 17,587 | $304K | 5/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 17,587 | $1.3M | 5/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 16,351 | $267K | 4/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 16,351 | $1.1M | 4/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,186 | $0 | 2/18/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 541 | $36K | 2/18/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,500 | $0 | 2/17/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 685 | $45K | 2/17/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,273 | $0 | 2/16/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 581 | $38K | 2/16/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,115 | $0 | 2/14/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 965 | $64K | 2/14/2024 | View on chart |
| BSX | ▲ Buy | Grant | 12,000 | $0 | 2/6/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 5,472 | $0 | 2/6/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 7,848 | $0 | 1/1/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 3,729 | $216K | 1/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,203 | $0 | 5/2/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,917 | $101K | 5/2/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 4,000 | $200K | 3/31/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,091 | $0 | 2/21/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 498 | $23K | 2/21/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 541 | $25K | 2/18/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,186 | $0 | 2/18/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,500 | $0 | 2/17/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 685 | $32K | 2/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,272 | $0 | 2/16/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 581 | $27K | 2/16/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,200 | $0 | 2/15/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 548 | $26K | 2/15/2023 | View on chart |
| BSX | ▼ Sell | Gift | 4,779 | $0 | 2/6/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,202 | $0 | 1/1/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,463 | $68K | 1/1/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,222 | $0 | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 374 | $17K | 2/28/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,090 | $0 | 2/21/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 334 | $14K | 2/21/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 363 | $15K | 2/18/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,186 | $0 | 2/18/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,500 | $0 | 2/17/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 459 | $20K | 2/17/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,200 | $0 | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 368 | $16K | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Gift | 1,767 | $0 | 2/8/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 13,167 | $569K | 2/7/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,929 | $0 | 1/1/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,382 | $59K | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate
Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.